Valuation: Genpharmasec Limited

Market Cap 432M 4.52M 3.93M 3.65M 3.37M 6.34M 6.45M 43.2M 16.91M 215M 16.99M 16.62M 721M P/E 2024
-545x
P/E 2025 94.5x
Enterprise Value 422M 4.43M 3.84M 3.57M 3.29M 6.2M 6.31M 42.26M 16.55M 210M 16.62M 16.26M 706M EV / Sales 2024
3.47x
EV / Sales 2025 2.96x
Free-Float
56.99%
Yield 2024 *
-
Yield 2025 -
1 week+0.97%
Current month-5.45%
1 month-5.45%
3 months-14.75%
6 months-11.11%
Current year-20.61%
1 week 0.99
Extreme 0.99
1.05
1 month 0.99
Extreme 0.99
1.19
Current year 0.75
Extreme 0.75
1.45
1 year 0.75
Extreme 0.75
2.2
3 years 0.75
Extreme 0.75
8.71
5 years 0.75
Extreme 0.75
12.4
10 years 0.75
Extreme 0.75
18
Manager TitleAgeSince
Director of Finance/CFO 38 01/11/2022
Compliance Officer - 27/03/2024
Director TitleAgeSince
Director/Board Member 57 02/01/2019
Director/Board Member 58 02/01/2019
Director/Board Member - 01/11/2022
Change 5-day change 1-year change 3-year change Capi.($)
0.00%+0.97%-47.21%-67.19% 6.03M
-2.21%+4.82%-17.85%-6.32% 183B
-2.09%+4.51%-6.47%-2.88% 110B
-2.00%+2.35%+7.00%+67.36% 60.75B
+3.50%+0.47%+28.65%+49.27% 50.01B
-1.75%+8.16%-8.86%-40.98% 45.59B
-2.40%+3.96% - - 33.08B
-0.80%+5.76%-16.30%-43.69% 28.76B
+0.63%-4.47%+36.27%-7.08% 23.9B
-1.54%+9.77%+0.85%+0.51% 22.53B
Average -0.87%+3.55%-2.66%-5.67% 55.71B
Weighted average by Cap. -1.40%+5.48%-4.01%+3.44%

Financials

2024 2025
Net sales 304M 3.18M 2.77M 2.57M 2.37M 4.46M 4.54M 30.41M 11.91M 151M 11.96M 11.7M 508M 337M 3.53M 3.07M 2.85M 2.63M 4.95M 5.04M 33.73M 13.21M 167M 13.26M 12.97M 563M
Net income -1.26M -13.17K -11.44K -10.62K -9.79K -18.45K -18.78K -126K -49.23K -624K -49.44K -48.36K -2.1M 12.31M 129K 112K 104K 95.93K 181K 184K 1.23M 482K 6.11M 484K 474K 20.56M
Net Debt -179M -1.87M -1.63M -1.51M -1.39M -2.63M -2.67M -17.89M -7.01M -88.84M -7.04M -6.88M -299M -9.4M -98.49K -85.55K -79.44K -73.27K -138K -141K -941K -368K -4.67M -370K -362K -15.7M
Logo Genpharmasec Limited
Genpharmasec Limited is an India-based company, which is engaged in the distribution of diagnostic pharma equipment and trading of securities. The Company’s segments include Pharmaceuticals, Trading in Securities, and Laboratory Testing. The Trading in Securities segment invests in the secondary securities market. The Company holds rights to the distribution of equipment, such as i-STAT Analyzers and its Cartridges, manufactured by Abbott Point of Care, USA, all over India. The i-STAT Analyzer is a blood analyzer used in Intensive Care Units (ICUs) of hospitals and provides test results in approximately 10 minutes. The Company’s wholly owned subsidiary includes M/s. Clinigenome India Private Limited.
Employees
10
Date Price Change Volume
31/07/26 1.040 0.00% 295,001
30/07/26 ₹1.040 +0.97% 179,169
29/07/26 ₹1.030 +0.98% 184,503
28/07/26 ₹1.020 -1.92% 266,476
27/07/26 ₹1.040 +1.96% 216,483
  1. Stock Market
  2. Stocks
  3. ADIRASA Stock